Fawzia Z El-Ablack^1*, Mayada A El-Zakzouk¹ and Faten Z Mohamed²

¹Chemistry Department, Faculty of Science, Damietta University, New Damietta, Egypt
²2Chemistry Department, Faculty of Science, Zagazig University, Zagazig, Egypt

*Corresponding Author:Khushbu, Department of Zoology and Aquaculture, Chaudhary Charan Singh Haryana Agriculture University, Hisar, Haryana, India.

Received: July 28, 2022; Published: Novemmber 29, 2022

Abstract

In trying to develop new anticancer agents, 5,7-diamino-6- (benzo [d]thiazol-2-yl)-3-phenylthiazolo [4,5-b] pyridine-2 (3H)-thione derivative was designed, synthesized. The design was based on a molecular hybridization approach and evaluated in-vitro for their anti-proliferative activity against human hepatocellular carcinoma cell line HePG-2, human breast adenocarcinoma MCF-7, colorectal carcinoma HCT-116, and Human prostate cancer PC-3 cell lines using a colorimetric MTT assay.
Additionally, the synthesized compounds are also tested for their in vitro antioxidant activity by DPPH methods in which compounds exhibited good antioxidant activity. The calf thymus DNA binding activity of enaminonitrile thiazole compound and benzo [d]thiazol-2-yl pyridine derivative were studied by UV-Vis absorption titration and viscosity measurements also molecular docking of the tested compounds was carried out to investigate the DNA binding affinity of the tested compound with the prospective target, DNA (PDB-: 1BNA;6BNA).The results suggest that these compounds bind to DNA in an intercalative mode and the intrinsic binding constants (Kb) of diamino-benzo [d]thiazol-2-yl-thiazoe-and enaminonitrile thiazole with CT-DNA were found to be (7.24 × 105 and 5.59 × 105 M-1 ). The antimicrobial activities of thiazole derivative were tested against gram negative bacteria (Escherichia coli, Klebsilla pneumonia and Pseudomonas sp), gram positive bacteria (Staphylococcus aureus, Bacillus cereus) and fungal (Aspergillus niger, Fusarium oxysporum and Candida albicans). Docking calculations were carried out using Docking Server (Bikadi, Hazai, 2009). Besides, the docking results for synthesized derivatives were in agreement with the in vitro antitumor results.

Keywords: Anticancer; Thiazole; DNA Binding; Anti-Proliferative Activity; Molecular Docking; Thiazolo [5,4-b] Pyridine; Cytotoxicity and Antimicrobial Activity

References

1. Sun C., et al. “Synthesis and anticancer activity of novel 4-morpholino-7,8-dihydro-5H-thiopyrano [4,3-d] pyrimidine derivatives bearing chromone moiety”. Bioorganic and Medicinal Chemistry16 (2016): 3862-3869.
2. Lino CI., et al. “Synthesis, molecular modelling studies and evaluation of antifungal activity of a novel series of thiazole derivatives”. European Journal of Medicinal Chemistry 151 (2018): 248-260.
3. Reddy GM., et al. “Synthesis, antimicrobial activity and advances in structure-activity relationships (SARs) of novel tri-substituted thiazole derivatives”. European Journal of Medicinal Chemistry 123 (2016): 508-513.
4. Cushman MS., et al. “Antimicrobial substituted thiazoles and methods of use”. United States Patent No.: US 9 (2016): 801-861B2.
5. Leoni A., et al. “Novel thiazole derivatives: a patent review (2008-2012; Part 1)”. Expert Opinion on Therapeutic Patents 24 (2014): 201-216.
6. Sinha S., et al. “Design, synthesis and identification of novel substituted 2-amino thiazole analogues as potential anti-inflammatory agents targeting 5-lipoxygenase”. European Journal of Medicinal Chemistry 158 (2018): 34-50.
7. Kamble RD., et al. “Synthesis and in silico investigation of thiazoles bearing pyrazoles derivatives as anti-inflammatory agents”. Computational Biology and Chemistry 61 (2016): 86-96.
8. Pember SO., et al. “Piperidinyl thiazole isoxazolines: a new series of highly potent, slowly reversible FAAH inhibitors with analgesic properties”. Bioorganic and Medicinal Chemistry Letters 26 (2016): 2965-2973.
9. Wang Y., et al. “Design, synthesis and biological evaluation of novel β-pinene-based thiazole derivatives as potential anticancer agents via mitochondrial-mediated apoptosis pathway”. Bioorganic Chemistry 84 (2019): 468-477.
10. Santana TI., et al. “Synthesis, anticancer activity and mechanism of action of new thiazole derivatives”. European Journal of Medicinal Chemistry 144 (2014): 886-874.
11. Bell FW., et al. “Phenethylthiazolethiourea (PETT) compounds, a new class of HIV-1 reverse transcriptase inhibitors. 1. Synthesis and basic structure-activity relationship studies of PETT analogs”. Journal of Medicinal Chemistry25 (2011): 4929-4936.
12. Amin KM., et al. “Synthesis and preliminary evaluation of some substituted coumarins as anticonvulsant agents”. Bioorganic and Medicinal Chemistry 16 (2008): 5377-3588.
13. González Cabrera D., et al. “Novel orally active antimalarial thiazoles”. Journal of Medicinal Chemistry21 (2011): 7713-7719.
14. Chen C., et al. “Synthesis and Biological Evaluation of Thiazole Derivatives as Novel USP7 Inhibitors”. Bioorganic and Medicinal Chemistry Letters 27 (2017): 845-849.
15. Piechowska K., et al. “Discovery of Tropinone-Thiazole Derivatives as Potent Caspase 3/7 Activators, and Non-competitive Tyrosinase Inhibitors with High Antiproliferative Activity: Rational Design, One-Pot Tricomponent Synthesis, and Lipophilicity Determination”. European Journal of Medicinal Chemistry 175 (2019): 162-171.
16. Carter JS., et al. “Synthesis and activity of sulfonamide-substituted 4, 5-diaryl thiazoles as selective cyclooxygenase-2 inhibitors”. Bioorganic and Medicinal Chemistry Letters8 (2011): 1171-1174.
17. Badorc A., et al. “New orally active non-peptide fbrinogen receptor (GpIIb-IIIa) antagonists: identifcation of ethyl 3-[N-[4-[4-[amino [(ethoxycarbonyl)imino] methyl] phenyl]-1, 3-thiazol2-yl]-N-[1-[ (ethoxycarbonyl) methyl] piperid-4-yl] amino] propionate (SR 121787) as a potent and long-acting antithrombotic agent”. Journal of Medicinal Chemistry 21 (2011): 3393-3401.
18. Rudolph J., et al. “seco-Cyclothialidines: new concise synthesis, inhibitory activity toward bacterial and human DNA topoisomerases, and antibacterial properties”. Journal of Medicinal Chemistry4 (2011): 619-626.
19. Paulvannan K and Chen T. "Solid-phase synthesis of 1,2,3,4-tetrahydro-2-pyridones via aza-annulation of enamines”. The Journal of Organic Chemistry 65 (2000): 6160-6166.
20. Easmon J., et al. “Synthesis, structure-activity relationships, and antitumor studies of 2-benzoxazolyl hydrazones derived from alpha- (N)-acyl heteroaromatics”. Journal of Medicinal Chemistry 49 (2006): 6343-6350.
21. Kovala-Demertzi D., et al. “Synthesis, characterization, crystal structures, in vitro and in vivo antitumor activity of palladium (II) and zinc (II) complexes with 2-formyl and 2-acetyl pyridine N (4)-1- (2-pyridyl)-piperazinyl thiosemicarbazone”. Polyhedron 27 (2008): 2731-2738.
22. Illán-Cabeza NA., et al. “New 2,6-bis-[uracil-imino] ethylpyridine complexes containing the CdN6 core: synthesis, crystal structures, luminescent properties and antiproliferative activity against C6 glioma cells”. Journal of Inorganic Biochemistry 103 (2009): 1176-1184.
23. Patrick DA., et al. “Urea derivatives of 2-aryl-benzothiazol-5-amines: A new class of potential drugs for human African trypanosomiasis”. Journal of Medicinal Chemistry 60 (2017): 957-971.
24. Racane L., et al. “Synthesis and antioxidative potency of novel amidino substituted benzimidazole and benzothiazole derivatives”. Croatica Chemica Acta 90 (2017): 187-195.
25. Worachartcheewan A., et al. “Antioxidant, cytotoxicity, and QSAR study of 1-adamantylthio derivatives of 3-picoline and phenyl pyridines”. Medicinal Chemistry Research 21 (2012): 3514-3522.
26. Chavan V., et al. “Synthesis, characterization, and biological activities of some 3,5,6-trichloropyridine derivatives”. Chemistry of Heterocyclic Compounds 42 (2006): 625-630.
27. Zav’yalova VK., et al. “Synthesis and reactions of 3-acetyl-6-methyl-2- (methylthio) pyridine”. Russian Chemical Bulletin 58 (2009): 1939-1944.
28. Patel NB., et al. “Synthesis and antimicrobial activity of new pyridine derivatives-I”. Medicinal Chemistry Research 20 (2011): 1033-1041.
29. Muthal N., et al. “Synthesis, antimicrobial and anti-infammatory activity of some 5-substituted-3-pyridine-1, 2, 4-triazoles”. International Journal of PharmTech Research 2 (2010): 2450-2455.
30. Khidre RE., et al. “Design, synthesis, and antimicrobial evaluation of some novel pyridine, coumarin, and thiazole derivatives”. Journal of Heterocyclic Chemistry 54 (2017): 2511-2519.
31. Khidre RE., et al. “Synthesis of a novel heterocyclic scafold utilizing 2-cyano-N- (3-cyano-4,6-dimethyl-2-oxopyridin-1-yl) acetamide”. ARKIVOC (2016): 1-17.
32. El-Hawash SAM., et al. “Cyanoacetic acid hydrazones of 3-(and 4-) acetylpyridine and some derived ring systems as potential antitumor and anti-HCV agents”. Archiv der Pharmazie 339 (2006): 14-23.
33. Vrábel M., et al. “Purines bearing phenanthroline or bipyridine ligands and their RuII complexes in position 8 as model compounds for electrochemical DNA labeling-synthesis, crystal structure, electrochemistry, quantum chemical calculations, cytostatic and antiviral activity”. European Journal of Inorganic Chemistry (2007): 1752-1769.
34. Firke S., et al. “Synthetic and pharmacological evaluation of some pyridine containing thiazolidinones”. Asian Journal of Research in Chemistry 2 (2009): 157-161.
35. Pathak N., et al. “A Review on Anticancer Potentials of Benzothiazole Derivatives”. Mini-Reviews in Medicinal Chemistry 20 (2020): 12-23.
36. Hassan AY., et al. “Design, Synthesis, and Anticancer Activity of Novel Benzothiazole Analogues”. Journal of Heterocyclic Chemistry 56 (2019): 1437-1457.
37. Hassan AY and Hussein EM. “Synthesis and Anticancer Evaluation of Some Novel Thiophene, Thieno [3,2-d] pyrimidine, Thieno [3,2- b] pyridine, and Thieno [3,2-e] [1,4] oxazepine Derivatives Containing Benzothiazole Moiety”. Journal of Heterocyclic Chemistry 56 (2019): 2419-2429.
38. Rao AVS., et al. “2-Arylamino-benzothiazole-arylpropenone conjugates as tubulin polymerization inhibitors”. MedChemComm 8 (2017): 924-941.
39. Matysiak J., et al. “Synthesis and biological activity of novel benzoazoles, benzoazines and other analogs functionalized by 2,4-dihydroxyphenyl moiety”. Research on Chemical Intermediates 44 (2018): 6169-6182.
40. Yang ML., et al. “Design, Synthesis, and Evaluation of Bis-Benzothiazole Derivatives as DNA Minor Groove Binding Agents”. Journal of Heterocyclic Chemistry 55 (2018): 360-365.
41. Racane L., et al. “Green synthesis and biological evaluation of 6-substituted-2-(2-hydroxy/methoxyphenyl) benzothiazole derivatives as potential antioxidant, antibacterial and antitumor agents”. Bioorganic Chemistry 95 (2020): 103537.
42. Maddila S., et al. “Synthesis, antibacterial and antifungal activity of novel benzothiazole pyrimidine derivatives”. Arabian Journal of Chemistry 9 (2016): 681-687.
43. Abdelgawad MA., et al. “Design, synthesis and biological evaluation of some novel benzothiazole/benzoxazole and/or benzimidazole derivatives incorporating a pyrazole scaffold as antiproliferative agents”. Bioorganic Chemistry 74 (2017): 82-90.
44. Singh M., et al. “Design and Synthesis of Novel Schiff Base-Benzothiazole Hybrids as Potential Epidermal Growth Factor Receptor (EGFR) Inhibitors”. Anti-Cancer Agents in Medicinal Chemistry 16 (2016): 722-739.
45. Liu K., et al. “Synthesis and antiproliferative activity of new n-acylhydrazone derivatives containing Benzothiazole and indole-based moiety”. Pharmaceutical Chemistry Journal 54 (2020): 345-352.
46. Narva S., et al. “Design, Synthesis, and Biological Evaluation of 2- (4-Aminophenyl) benzothiazole Analogues as Antiproliferative Agents”. Journal of Heterocyclic Chemistry 56 (2019): 520-532.
47. Afzal O., et al. “Hit to lead optimization of a series of N-[4-(1,3-benzothiazol2-yl) phenyl] acetamides as monoacylglycerol lipase inhibitors with potential anticancer activity”. European Journal of Medicinal Chemistry 121 (2016): 318-330.
48. Dhumal ST., et al. “Copper fluorapatite assisted synthesis of new 1,2,3-triazoles bearing a benzothiazolyl moiety and their antibacterial and anticancer activities”. New Journal of Chemistry 43 (2019): 7663-7673.
49. Subramanyam M., et al. “Synthesis, Biological Evaluation and Docking Studies of 1,3,4-oxadiazole Fused Benzothiazole Derivatives for Anticancer Drugs”. Letters in Drug Design and Discovery 15 (2018): 1299-1307.
50. Chhabra M., et al. “An efficient green synthesis of 2-arylbenzothiazole analogues as potent antibacterial and anticancer agents”. Bioorganic and Medicinal Chemistry Letters 26 (2016): 213-217.
51. Racane L., et al. “Novel 2-thienyl- and 2-benzothienyl-substituted 6-(2-imidazolinyl) benzothiazoles: Synthesis; in vitro evaluation of antitumor effects and assessment of mitochondrial toxicity”. Anti-Cancer Agents in Medicinal Chemistry 17 (2017): 57-66.
52. Racane L., et al. “Eco-friendly synthesis, in vitro anti-proliferative evaluation, and 3D-QSAR analysis of a novel series of monocationic 2-aryl/heteroaryl-substituted 6-(2-imidazolinyl) benzothiazole mesylates”. Molecular Diversity 22 (2018): 723-741.
53. Cindri´c M., et al. “Novel amidino substituted benzimidazole and benzothiazole benzo [b] thieno-2-carboxamides exert strong antiproliferative and DNA binding properties”. European Journal of Medicinal Chemistry 136 (2017): 468-479.
54. Bhat M., et al. “Synthesis and characterization of novel benzothiazole amide derivatives and screening as possible antimitotic and antimicrobial agents”. Research on Chemical Intermediates 43 (2017): 361-378.
55. Singh M., et al. “Design, synthesis and mode of action of novel 2-(4-aminophenyl) benzothiazole derivatives bearing semicarbazone and thiosemicarbazone moiety as potent antimicrobial agents”. Medicinal Chemistry Research 25 (2016): 263-282.
56. Dar AA., et al. “One-Pot Synthesis and Evaluation of Antileishmanial Activities of Functionalized S-Alkyl/Aryl Benzothiazole-2-carbothioate Scaffold”. The Journal of Organic Chemistry 81 (2016): 3149-3160.
57. Padalkar VS., et al. “Synthesis and antimicrobial activity of novel 2-substituted benzimidazole, benzoxazole and benzothiazole derivatives”. Arabian Journal of Chemistry 9 (2016): 1125-1130.
58. Mishra VR., et al. “Design, synthesis, antimicrobial activity and computational studies of novel azo linked substituted benzimidazole, benzoxazole and benzothiazole derivatives”. Computational Biology and Chemistry 78 (2019): 330-337.
59. Alborz M., et al. “Synthesis and biological evaluation of some novel diastereoselective benzothiazole b-lactam conjugates”. European Journal of Medicinal Chemistry 143 (2018): 283-291.
60. Gondru R., et al. “Design, Synthesis, In Vitro Evaluation and Docking Studies of Pyrazole-Thiazole Hybrids as Antimicrobial and Antibiofilm Agents”. Chemistry Select 3 (2018): 8270-8276.
61. Kumar P., et al. “Synthesis of some benzothiazoles by developing a new protocol using urea nitrate as a catalyst and their antimicrobial activities”. Journal of Sulfur Chemistry 38 (2017): 585-596.
62. Fadda AA., et al. “Convenient route synthesis of some new benzothiazole derivatives and their pharmacological screening as antimicrobial agents”. Annals of Advances in Chemistry 1 (2017): 032-046.
63. Kamo M., et al. “Synthesis of the biotinylated anti-HIV compound BMMP and the target identification study”. Bioorganic and Medicinal Chemistry Letters 26 (2016): 43-45.
64. Halim SA., et al. “Targeting Dengue Virus NS-3 Helicase by Ligand based Pharmacophore Modeling and Structure based Virtual Screening”. Frontiers in Chemistry 5 (2017): 1-16.
65. Liu L., et al. “Efficient synthesis of benzothiazole derivatives by reaction of bis (2-aminophenyl) disulfides with aldehydes mediated by NaSH under microwave irradiation”. Phosphorus Sulfur Silicon 192 (2017): 464-468.
66. Stremski Y., et al. “Synthesis and antibacterial activity of hydroxylated 2-arylbenzothiazole derivatives”. Synthetic Communications 50 (2020): 3007-3015.
67. Xie XY., et al. “Visible Light-Induced Metal-Free and Oxidant-Free Radical Cyclization of (2-Isocyanoaryl)-(methyl) sulfanes with Ethers”. European Journal of Organic Chemistry (2021): 4273-4277.
68. Ashraf M., et al. “Design and synthesis of cis-restricted benzimidazole and benzothiazole mimics of combretastatin A-4 as antimitotic agents with apoptosis inducing ability”. Bioorganic and Medicinal Chemistry Letters 26 (2016): 4527-4535.
69. Lasing T., et al. “Synthesis and antileishmanial activity of fluorinated rhodacyanine analogues: The ‘fluorine-walk’ analysis”. Bioorganic and Medicinal Chemistry 28 (2020): 115187.
70. Patrick DA., et al. “Urea derivatives of 2-aryl-benzothiazol-5-amines: A new class of potential drugs for human African trypanosomiasis”. Journal of Medicinal Chemistry 60 (2017): 957-971.
71. , et al. “Synthesis and antioxidative potency of novel amidino substituted benzimidazole and benzothiazole derivatives”. Croatica Chemica Acta 90 (2017): 187-195.
72. Bhutani R., et al. “Synthesis, molecular modelling studies and ADME prediction of benzothiazole clubbed oxadiazole-Mannich bases, and evaluation of their anti-diabetic activity through in vivo model”. Bioorganic Chemistry 77 (2018): 6-15.
73. Khan KM., et al. “The immunomodulation potential of the synthetic derivatives of benzothiazoles: Implications in immune system disorders through in vitro and in silico studies”. Bioorganic Chemistry 64 (2016): 21-28.
74. Salem ME., et al. “Synthesis of novel scaffolds based on thiazole or triazolothiadiazine linked to benzofuran or benzo[d]thiazole moieties as new hybrid molecules”. Synthetic Communications 50 (2020): 256-270.
75. Kaplan-Ozen C., et al. “Benzothiazole derivatives as human DNA topoisomerase IIα inhibitors”. Medicinal Chemistry Research12 (2006): 5798-5808.
76. Oanh DTK., et al. “Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents”. Bioorganic and medicinal chemistry letters24 (2006): 7509-7512.
77. Hassan AY., et al. “Design, Synthesis, and Anticancer Activity of Novel Benzothiazole Analogues”. Journal of Heterocyclic Chemistry4 (2006): 1437-1457.
78. Salem ME., et al. “Synthesis of novel scaffolds based on thiazole or triazolothiadiazine linked to benzofuran or benzo[d]thiazole moieties as new hybrid molecules”. Synthetic Communications 50 (2020): 256-270.
79. El-Ablack FZ., et al. “Synthesis, characterization, in- vitro Anti diabetic Activity, molecular docking and DNA binding of a novel thiazole derivatives”. JCBPS Section A 10 (2020): 271-293.
80. EL-Ablack FZ. “Synthesis of Some New Benzimidazole Derivatives of Pharmaceutical Interest”. E-Journal of Chemistry2 (2011): 748-752.
81. El-Ablack FZ. “Synthesis of some new thiazole derivatives of pharmaceutical interest”. Bollettino Chimico Farmaceutico 9 (2003): 406‐409.
82. Marmur J. “A procedure for the isolation of deoxyribonucleic acid from micro-organisms”. Journal of Molecular Biology 2 (1961): 208-218.
83. Reichmann ME., et al. “Further Examination of the Molecular Weight and Size of Deoxy pentose Nucleic Acid”. Journal of the American Chemical Society 76 (1954): 3047-3053.
84. Wolfe A., et al. “Polycyclic aromatic hydrocarbons physically intercalate into duplex regions of denatured DNA”. Biochemistry 26 (1987): 6392-6396.
85. Sudeepa K., et al. “Synthesis, spectral characterization, antimicrobial, DNA interactions and molecular modeling studies of metal complexes of 1, 3-benzothiazole carbohydrazone”. Journal of Chemical Sciences5 (2018): 52.
86. Yousif E., et al. “Synthesis and photostability study of some modified poly (vinyl chloride) containing pendant benzothiazole and benzimidozole ring”. International Journal of Chemistry1 (2010): 65.
87. Guo H., et al. “Synthesis, DNA-binding, cytotoxicity, and cleavage studies of unsymmetrical oxovanadium complexes”. Journal of Coordination Chemistry2 (2012): 191-204.
88. Rohs R., et al. “Molecular flexibility in ab initio drug docking to DNA: binding-site and binding-mode transitions in all-atom Monte Carlo simulations”. Nucleic Acids Research22 (2005): 7048-7057.
89. Morris GM., et al. “Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function”. Journal of Computational Chemistry14 (1998): 1639-1662.
90. Mosmann T. “Rapid colorimetric assay for cellular growth and survival application to proliferation and cytotoxicity assays”. Journal of Immunological Methods1-2 (1983): 55-63.
91. Scudiero DA., et al. “Evaluation of a soluble tetrazolium/formazan assay for cell growth and drug sensitivity in culture using human and other turnout cell lines”. Cancer Research 48 (1988): 4827-4833.
92. Yen GC and Duh PD. “Scavenging effect of methanolic extracts of peanut hulls on free radical and active oxygen species”. Journal of Agricultural and Food Chemistry 42 (1994): 629-632.
93. Bikadi Z and Hazai E. “Application of the PM6 semi-empirical method to modeling proteins enhances docking accuracy of AutoDock”. Journal of Chemical Information 1 (2009): 15.
94. Solis FJ and Wets RJB. “Minimization by Random Search Techniques Mathematics of Operations Research”. The Institute for Operations Research and the Management Sciences1 (1981): 19-30.
95. N Trotsko., et al. “Synthesis and antibacterial activity of new (2,4-dioxothiazolidin-5-yl/ ylidene) acetic acid derivatives with thiazolidine-2,4-dione, rhodanine and 2-thiohydantoin moieties”. Saudi Pharmaceutical Journal 26 (2018): 568-577.
96. Azab ME. “Utility of the enaminonitrile moiety in the synthesis of some biologically active thienopyrimidine derivatives”. Phosphorus, Sulfur, and Silicon and the Related Elements 183 (2008): 1766-1782.
97. Madkour HMF., et al. “Synthetic utility of enaminonitrile moiety in heterocyclic synthesis: Synthesis of some new thienopyrimidine”. Phosphorus, Sulfur, and Silicon and the Related Elements 184 (2009): 719-732.
98. Shaaban MR., et al. “Synthesis and Antimicrobial Evaluation of New Thiophene and 1,3,4-Thiadiazole Derivatives”. Heterocycles 78 (2009): 151-159.
99. Wamhoff H., et al. “Uracils: versatile starting materials in heterocyclic synthesis”. Advances in Heterocyclic Chemistry 55 (1992): 129.
100. Rao AU., et al. “Synthesis and Structure-activity Relationships of 2- (1,40 -bipiperidin-10 -yl)thiazolopyridine as H3 Receptor Antagonists”. Bioorganic and Medicinal Chemistry Letters 19 (2009): 6176-6180.
101. Kale MG., et al. “Thiazolopyridine Ureas as Novel Antitubercular Agents Acting through Inhibition of DNA Gyrase”. British Journal of Medicinal Chemistry 56 (2013): 8834-8848.
102. Xie X., et al. “Synthesis and Anticancer Effects Evaluation of 1-alkyl-3- (6- (2-methoxy-3-sulfonylaminopyridin-5-yl)benzo[d]thiazol-2-yl)urea as Anticancer Agents with Low Toxicity”. Bioorganic and Medicinal Chemistry 23 (2015): 6477-6485.
103. Bebernitz GR., et al. “Investigation of Functionally Liver Selective Glucokinase Activators for the Treatment of Type 2 Diabetes”. Journal of Medicinal Chemistry 52 (2009): 6142-6152.
104. Liu P., et al. “Targeting the Phosphoinositide 3-kinase Pathway in Cancer”. Nature Reviews Drug Discovery 8 (2009): 627-644.
105. Kesavan MP., et al. “DNA interaction, antimicrobial, antioxidant and anticancer studies on Cu (II) complexes of Luotonin A”. Journal of Photochemistry and Photobiology B: Biology 167 (2017): 20-28.
106. Nunhart P., et al. “Antimicrobial activity and DNA/HSA interaction of fluorinated 3, 6, 9-trisubstituted acridines”. Chemical7 (2020): 2327-2337.
107. Berry M., et al. “Practical considerations in virtual screening and molecular docking”. Emerging trends in computational biology”. Bioinformatics and Systems Biology (2015): 487.
108. Perez S and Tvaroska I. “Carbohydrate ̌ -protein interactions: Molecular modeling insights”. Advances in Carbohydrate Chemistry and Biochemistry 71 (2014): 9-136.
109. Pearson RG. “Absolute Electronegativity and Hardness: Applications to Organic Chemistry”. The Journal of Organic Chemistry 54 (1989): 1423.
110. Pearson RG. “The principle of maximum hardness”. Accounts of Chemical Research 26 (1993): 250-255.
111. Sagdinc S., et al. “Theoretical and spectroscopic studies of 5-fluoro-isatin-3- (N-benzylthiosemicarbazone) and its zinc (II) complex”. Journal of Molecular Structure 917 (2009): 63-70.
112. Padmanabhan J., et al. “Electrophilicity-Based Charge-Transfer Descriptor”. The Journal of Physical Chemistry 111 (2011): 1358-1361.
113. Parr RG., et al. “Electrophilicity Index”. Journal of the American Chemical Society 121 (1999): 1922-1924.
114. Aljahdali M and El-Sherif AA. “Synthesis, Characterization, Molecular Modeling and Biological Activity of Mixed Ligand Complexes of Cu (II), Ni (II) and Co (II) Based on 1,10-Phenanthroline and Novel Thiosemicarbazone”. Inorganica Chimica Acta 407 (2011): 58-68.
115. Aboafia SA., et al. “New transition metal complexes of 2, 4-dihydroxybenzaldehyde benzoylhydrazone Schiff base (H2dhbh): synthesis, spectroscopic characterization, DNA binding/cleavage and antioxidant activity”. Journal of Molecular Structure 1158 (2011): 39-50.
116. Raja DS., et al. “A novel water-soluble ligand bridged cobalt (II) coordination polymer of 2-oxo-1, 2-dihydroquinoline-3-carbaldehyde (isonicotinic) hydrazone: evaluation of the DNA binding, protein interaction, radical scavenging and anticancer activity”. Dalton Transactions15 (2011): 4365-4377.
117. Gao G and Liang C. “Electrochemical and DFT studies of β-amino-alcohols as corrosion inhibitors for brass”. Electrochimica Acta 52 (2007): 4554.
118. Porta FA., et al. “Orbital signatures as a descriptor of regioselectivity and chemical reactivity: the role of the frontier orbitals on 1, 3-Dipolar cycloadditions”. The Journal of Physical Chemistry A 115 (2011): 824-833.

Citation

Citation: Fawzia Z El-Ablack., et al. “Design, Synthesis, Anticancer Evaluation, DNA Binding and Molecular Docking of a Novel Thiazolo [5,4-b] Pyridine Derivatives". Acta Scientific Pharmacology 3.12 (2022): 17-35.

Copyright

Copyright: © 2022 Fawzia Z El-Ablack., et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.